PROTECT-trial
Proton versus photon therapy for esophageal cancer - a trimodality strategy
- Started
- 2021-07-01
- Website
- https://protecttrial.eu/
Proton versus photon therapy for esophageal cancer - a trimodality strategy
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
Saracatinib trial to prevent FOP
Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments
Academia and industry united innovation and treatment for tuberculosis
Inhaled antibiotics in bronchiectasis and cystic fibrosis